Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings

August 28, 2017 updated by: Lumenis Be Ltd.
Twenty (20) subjects presenting with a renal stone and candidates for FURS (flexible ureteroscopic renal surgery) will undergo a single FURS procedure for a kidney stone as part of the study, using the study device. These subjects will be randomized into stone breaking treatment or stone dusting.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 11215
        • New York Methodist Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Subject will be older than 18 years of age
  2. Subject was diagnosed with renal calculi meeting the following criteria:

    • Largest stone measures no more than 2cm on a single diameter and is no less than 0.8cm as defined by X-ray or CT.
    • Accumulative stone burden (addition of all stone diameters) is no more than 2.5cm.
  3. Subject is a candidate for FURS procedure
  4. Subject is willing and has signed the Informed Consent Form

Exclusion Criteria:

  1. Subject has undergone a previous treatment for stones in the same kidney
  2. Subject requires another, concomitant procedure, other than FURS, to be performed during this treatment session.
  3. Female subject is pregnant
  4. Concomitant anticoagulant medication that cannot be suspended during surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stone breaking
Lithotripsy will be performed using the Lumenis Pulse 120H holmium laser system with low frequency parameters.
The Lumenis Pulse P120H will be utilized in high and low frequencies according to subjects group allocation.
Experimental: Stone dusting
Lithotripsy will be performed using the Lumenis Pulse 120H holmium laser system with high frequency parameters.
The Lumenis Pulse P120H will be utilized in high and low frequencies according to subjects group allocation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stone Clearance
Time Frame: Stone clearance based on 1 month follow-up imaging data as compared to baseline
stone clearance will be confirmed by CT or X-Ray at 1 month follow up.
Stone clearance based on 1 month follow-up imaging data as compared to baseline
Duration of catheterization time
Time Frame: Change from 1 month to baseline
Duration of catheterization will be measured to evaluate treatment efficiency
Change from 1 month to baseline
Procedure time
Time Frame: during the procedure
duration of the procedure as an indicator for treatment efficiency.
during the procedure
Usage of alternative stone extracting devices
Time Frame: as measured during the procedure
The need of the surgeon to use baskets, forceps or saline flushing to achieve complete stone clearance. This outcome can influence both procedure time and further complication.
as measured during the procedure
hospital stay
Time Frame: Change from 1 month to baseline
hospital duration will be measured to evaluate treatment efficiency
Change from 1 month to baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative Complications
Time Frame: during the procedure and during 1 month follow up

Intraoperative Complications will be evaluated based on Modified Clavien Classification-

Modified Clavien Grading:

Grade 1,Grade 2,Grade 3,Grade 3a,Grade 3b,Grade 4,Grade 4a, Grade 4b, Grade 5.

during the procedure and during 1 month follow up
Visibility during procedure
Time Frame: during the procedure
clear vision of the stone and organ compartments as reflected via endoscope and video screen.
during the procedure
Occurrence of retropulsion that interferes with procedure
Time Frame: during the procedure
The subjective degree of stone movement and migration as a result of the laser treatment that interfere with procedure flow.
during the procedure
Fiber performance
Time Frame: during the procedure
The surgeon will evaluate the degree of Fiber flexibility with scope deflection- and any damage to fiber, Fiber durability- deflection without losing energy/ efficiency and any Damage to scope.
during the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Anticipated)

September 1, 2017

Study Completion (Anticipated)

September 1, 2017

Study Registration Dates

First Submitted

January 28, 2016

First Submitted That Met QC Criteria

February 11, 2016

First Posted (Estimate)

February 17, 2016

Study Record Updates

Last Update Posted (Actual)

August 29, 2017

Last Update Submitted That Met QC Criteria

August 28, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stone Clearance

3
Subscribe